Adcock invests $40M in Johannesburg facility; Accellent selling plant to Perryman;

> Thirty-three cases of a rare fungal eye infection have been traced to Franck's Compounding Lab in Ocala, FL, where tests of products by the FDA found drugs contaminated by a variety of fungi and bacteria. Story

> Adcock Ingram of South Africa has opened a $38.3 million manufacturing facility in Johannesburg to make sterile drip bags, ampules and dialysis solutions for the sub-Saharan Africa market. Item

> Accellent, a contract manufacturer for the medical device industry, has agreed to sell a 68,000-square-foot manufacturing facility in Houston, PA, near Pittsburgh, to titanium producer The Perryman Company for an undisclosed sum. Release

> FDA orders Alexza Pharmaceuticals ($ALXA) to fix manufacturing issues, which the company says are device-related, before it will approve its NDA for Adasuve, a schizophrenic and bipolar disorder treatment. Story

 

Suggested Articles

Neopharma, which has been buying and building plants for several years, is buying a sterile injectables plant and assets in Japan from India’s Lupin. 

Already knocked by the FDA four times this year, Dr. Reddy’s now has a fifth Form 483 to dwell on. This time it’s at a plant with a history of faults.

In a warning letter, the FDA details how a Chinese OTC drugmaker handed over documents faked just for the agency's inspection—and admitted it.